Item 1. Financial Statements
Item 1. Financial Statements.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(in millions, except share data)
3/31/2021 12/31/2020
ASSETS
Cash and cash equivalents $ 2,830.1 $ 2,151.7
Accounts receivable and accrued revenue 885.9 863.1
Investments 3,403.6 3,250.8
Assets of consolidated T. Rowe Price investment products ($ 1,782.9 million at March 31, 2021 and $ 2,497.4 million at December 31, 2020, related to variable interest entities)
1,946.8 2,695.5
Operating lease assets 110.2 117.6
Property and equipment, net 703.9 695.4
Goodwill 665.7 665.7
Other assets 218.2 219.2
Total assets $ 10,764.4 $ 10,659.0
LIABILITIES
Accounts payable and accrued expenses $ 228.9 $ 187.7
Liabilities of consolidated T. Rowe Price investment products ($ 49.0 million at March 31, 2021 and $ 47.7 million at December 31, 2020, related to variable interest entities)
53.7 57.7
Operating lease liabilities 146.0 154.1
Accrued compensation and related costs 260.8 133.6
Supplemental savings plan liability 769.9 772.2
Income taxes payable 284.0 85.0
Total liabilities 1,743.3 1,390.3
Commitments and contingent liabilities
Redeemable non-controlling interests 1,012.9 1,561.7
STOCKHOLDERS’ EQUITY
Preferred stock, undesignated, $ .20 par value – authorized and unissued 20,000,000 shares
— —
Common stock, $ .20 par value—authorized 750,000,000 ; issued 226,948,000 shares at March 31, 2021 and 227,965,000 at December 31, 2020
45.4 45.6
Additional capital in excess of par value 654.6 654.6
Retained earnings 7,338.7 7,029.8
Accumulated other comprehensive loss ( 30.5 ) ( 23.0 )
Total permanent stockholders’ equity 8,008.2 7,707.0
Total liabilities, redeemable non-controlling interests, and permanent stockholders’ equity $ 10,764.4 $ 10,659.0
The accompanying notes are an integral part of these statements.
Page 2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(in millions, except per-share amounts)
Three months ended
3/31/2021 3/31/2020
Revenues
Investment advisory fees $ 1,687.8 $ 1,327.8
Administrative, distribution, and servicing fees 139.0 134.8
Net revenues 1,826.8 1,462.6
Operating expenses
Compensation and related costs 583.5 440.7
Distribution and servicing 85.6 65.7
Advertising and promotion 18.9 24.9
Product-related costs 41.0 41.6
Technology, occupancy, and facility costs 117.3 105.4
General, administrative, and other 87.3 77.1
Total operating expenses 933.6 755.4
Net operating income 893.2 707.2
Non-operating income (loss)
Net gains (losses) on investments 68.6 ( 154.6 )
Net gains (losses) on consolidated investment products 37.2 ( 330.3 )
Other income (loss) ( 3.7 ) ( 15.4 )
Total non-operating income (loss) 102.1 ( 500.3 )
Income before income taxes 995.3 206.9
Provision for income taxes 230.5 40.3
Net income 764.8 166.6
Less: net income (loss) attributable to redeemable non-controlling interests 15.4 ( 176.5 )
Net income attributable to T. Rowe Price Group $ 749.4 $ 343.1
Earnings per share on common stock of T. Rowe Price Group
Basic $ 3.20 $ 1.43
Diluted $ 3.17 $ 1.41
The accompanying notes are an integral part of these statements.
Page 3
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in millions)
Three months ended
3/31/2021 3/31/2020
Net income $ 764.8 $ 166.6
Other comprehensive income (loss)
Currency translation adjustments
Consolidated T. Rowe Price investment products - variable interest entities ( 18.9 ) ( 25.1 )
Reclassification gains recognized in non-operating income upon deconsolidation of certain T. Rowe Price investment products ( 2.6 ) ( .1 )
Total currency translation adjustments of consolidated T. Rowe Price investment products - variable interest entities
( 21.5 ) ( 25.2 )
Equity method investments
( .8 ) ( .1 )
Other comprehensive loss before income taxes ( 22.3 ) ( 25.3 )
Net deferred tax benefits 3.0 2.0
Total other comprehensive loss ( 19.3 ) ( 23.3 )
Total comprehensive income 745.5 143.3
Less: comprehensive income (loss) attributable to redeemable non-controlling interests 3.6 ( 193.7 )
Total comprehensive income attributable to T. Rowe Price Group $ 741.9 $ 337.0
The accompanying notes are an integral part of these statements.
Page 4
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
Three months ended
3/31/2021 3/31/2020
Cash flows from operating activities
Net income $ 764.8 $ 166.6
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization of property and equipment
49.0 46.1
Stock-based compensation expense
57.5 58.3
Net (gains) losses recognized on investments ( 59.5 ) 167.3
Net change in T. Rowe Price investment products used to economically hedge supplemental savings plan liability 22.0 ( 8.9 )
Net change in securities held by consolidated T. Rowe Price investment products
( 120.9 ) 234.6
Other changes in assets and liabilities
281.8 123.7
Net cash provided by operating activities 994.7 787.7
Cash flows from investing activities
Purchases of T. Rowe Price investment products ( 12.5 ) ( 225.1 )
Dispositions of T. Rowe Price investment products 60.3 299.1
Net cash of T. Rowe Price investment products on deconsolidation ( 27.3 ) ( .8 )
Additions to property and equipment ( 58.8 ) ( 46.0 )
Other investing activity 7.5 .4
Net cash (used in) provided by investing activities ( 30.8 ) 27.6
Cash flows from financing activities
Repurchases of common stock ( 259.2 ) ( 891.3 )
Common share issuances under stock-based compensation plans 20.9 38.1
Dividends paid to common stockholders of T. Rowe Price Group ( 252.3 ) ( 215.2 )
Net subscriptions received from redeemable non-controlling interest holders 183.1 76.1
Net cash used in financing activities ( 307.5 ) ( 992.3 )
Effect of exchange rate changes on cash and cash equivalents of consolidated
T. Rowe Price investment products
.9 ( 1.2 )
Net change in cash and cash equivalents during period 657.3 ( 178.2 )
Cash and cash equivalents at beginning of period, including $ 104.8 million at December 31, 2020, and $ 76.5 million at December 31, 2019, held by consolidated T. Rowe Price investment products
2,256.5 1,858.3
Cash and cash equivalents at end of period, including $ 83.7 million at March 31, 2021, and $ 117.7 million at March 31, 2020, held by consolidated T. Rowe Price investment products
$ 2,913.8 $ 1,680.1
The accompanying notes are an integral part of these statements.
Page 5
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(shares in thousands; dollars in millions)
Three months ended 3/31/2021
Common
shares
outstanding
Common
stock
Additional
capital in
excess of
par value
Retained
earnings
AOCI (1)
Total
stockholders’
equity
Redeemable non-controlling interests
Balances at December 31, 2020 227,965 $ 45.6 $ 654.6 $ 7,029.8 $ ( 23.0 ) $ 7,707.0 $ 1,561.7
Net income — — — 749.4 — 749.4 15.4
Other comprehensive income (loss), net of tax — — — — ( 7.5 ) ( 7.5 ) ( 11.8 )
Dividends declared ($ 1.08 per share)
— — — ( 252.3 ) — ( 252.3 ) —
Shares issued upon option exercises 572 .1 25.3 — — 25.4 —
Net shares issued upon vesting of restricted stock units 41 — ( 3.7 ) — — ( 3.7 ) —
Stock-based compensation expense — — 57.5 — — 57.5 —
Restricted stock units issued as dividend equivalents — — .1 ( .1 ) — — —
Common shares repurchased ( 1,630 ) ( .3 ) ( 79.2 ) ( 188.1 ) — ( 267.6 ) —
Net subscriptions into T. Rowe Price investment products — — — — — — 187.5
Net deconsolidations of T. Rowe Price investment products — — — — — — ( 739.9 )
Balances at March 31, 2021 226,948 $ 45.4 $ 654.6 $ 7,338.7 $ ( 30.5 ) $ 8,008.2 $ 1,012.9
Three months ended 3/31/2020
Common
shares
outstanding Common
stock Additional
capital in
excess of
par value Retained
earnings AOCI (1)
Total
stockholders’
equity Redeemable non-controlling interests
Balances at December 31, 2019 235,214 $ 47.0 $ 654.6 $ 6,443.5 $ ( 43.0 ) $ 7,102.1 $ 1,121.0
Net income — — — 343.1 — 343.1 ( 176.5 )
Other comprehensive income (loss), net of tax — — — — ( 6.1 ) ( 6.1 ) ( 17.2 )
Dividends declared ($ 0.90 per share)
— — — ( 214.7 ) — ( 214.7 ) —
Shares issued upon option exercises 1,068 .2 41.1 — — 41.3 —
Net shares issued upon vesting of restricted stock units 37 — ( 3.0 ) — — ( 3.0 ) —
Stock-based compensation expense — — 58.3 — — 58.3 —
Restricted stock units issued as dividend equivalents — — .1 ( .1 ) — — —
Common shares repurchased ( 8,334 ) ( 1.6 ) ( 96.5 ) ( 788.9 ) — ( 887.0 ) —
Net subscriptions into T. Rowe Price investment products — — — — — — 63.8
Net deconsolidations of T. Rowe Price investment products — — — — — — ( 20.1 )
Balances at March 31, 2020 227,985 $ 45.6 $ 654.6 $ 5,782.9 $ ( 49.1 ) $ 6,434.0 $ 971.0
(1) Accumulated other comprehensive income.
The accompanying notes are an integral part of these statements.
Page 6
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 – THE COMPANY AND BASIS OF PREPARATION.
T. Rowe Price Group Inc. derives its consolidated revenues and net income primarily from investment advisory services that its subsidiaries provide to individual and institutional investors in the T. Rowe Price U.S. mutual funds (“U.S. mutual funds”), subadvised funds, separately managed accounts, collective investment trusts, and other
T. Rowe Price products. The other T. Rowe Price products include open-ended investment products offered to investors outside the U.S., and products offered through variable annuity life insurance plans in the U.S. We also provide certain investment advisory clients with related administrative services, including distribution, mutual fund transfer agent, accounting, and shareholder services; participant recordkeeping and transfer agent services for defined contribution retirement plans; brokerage; trust services; and non-discretionary advisory services through model delivery.
Investment advisory revenues depend largely on the total value and composition of assets under our management. Accordingly, fluctuations in financial markets and in the composition of assets under management impact our revenues and results of operations.
BASIS OF PRESENTATION.
These unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States. These principles require the use of estimates and reflect all adjustments that are, in the opinion of management, necessary for a fair statement of our results for the interim periods presented. All such adjustments are of a normal recurring nature. Actual results may vary from our estimates. Certain prior year amounts have been reclassified to conform to the 2021 presentation.
The unaudited interim financial information contained in these unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements contained in our 2020 Annual Report.
NEWLY ISSUED BUT NOT YET ADOPTED ACCOUNTING GUIDANCE
We have considered all newly issued accounting guidance that is applicable to our operations and the preparation of our unaudited condensed consolidated statements, including those we have not yet adopted. We do not believe that any such guidance has or will have a material effect on our financial position or results of operations.
NOTE 2 – INFORMATION ABOUT RECEIVABLES, REVENUES, AND SERVICES.
Revenues earned under agreements with clients include:
Three months ended 3/31/2021 Three months ended 3/31/2020
Administrative, distribution, and servicing fees
Administrative, distribution, and servicing fees
(in millions)
Investment advisory fees
Administrative fees
Distribution and servicing fees
Net revenues
Investment advisory fees
Administrative fees
Distribution and servicing fees
Net revenues
U.S. mutual funds $ 1,050.2 $ 78.7 $ 29.1 $ 1,158.0 $ 876.2 $ 77.2 $ 27.9 $ 981.3
Subadvised funds, separate accounts, collective investment trusts, and other investment products 637.6 — — 637.6 451.6 — — 451.6
Other clients (1)
— 31.2 — 31.2 — 29.7 — 29.7
$ 1,687.8 $ 109.9 $ 29.1 $ 1,826.8 $ 1,327.8 $ 106.9 $ 27.9 $ 1,462.6
(1) Other clients primarily include individuals, defined contribution plans, college savings plans, and institutions related to model delivery.
Total net revenues earned from our related parties, specifically T. Rowe Price investment products, aggregate $ 1,482.3 million and $ 1,207.7 million for the three months ended March 31, 2021 and 2020, respectively. Accounts
Page 7
receivable from these products aggregate to $ 540.0 million at March 31, 2021, and $ 523.4 million at December 31, 2020.
In the second quarter of 2020, we changed our fee structure of the target date retirement funds such that our investment advisory fee revenue is now earned at the target date retirement fund level rather than at the underlying mutual fund level. As a result, we have modified our investment advisory fee and assets under management presentation below to separately breakout the fees earned and assets under management of our multi-asset portfolios. All prior periods have been recast to conform to this new presentation and to provide comparability.
The following table details the investment advisory fees earned from clients by their underlying asset class.
Three months ended
(in millions) 3/31/2021 3/31/2020
U.S. mutual funds
Equity $ 729.8 $ 568.4
Fixed income, including money market 59.0 71.7
Multi-asset 261.4 236.1
1,050.2 876.2
Subadvised funds, separate accounts, collective investment trusts, and other investment products
Equity 429.8 279.5
Fixed income, including money market 31.7 38.0
Multi-asset 176.1 134.1
637.6 451.6
Total $ 1,687.8 $ 1,327.8
The following table summarizes the assets under management on which we earn investment advisory fees.
Average during
Three months ended As of
(in billions) 3/31/2021 3/31/2020 3/31/2021 12/31/2020
U.S. mutual funds
Equity $ 509.6 $ 388.3 $ 511.7 $ 498.6
Fixed income, including money market 82.3 75.7 82.6 79.4
Multi-asset 222.6 190.3 222.1 216.6
814.5 654.3 816.4 794.6
Subadvised funds, separate accounts, collective investment trusts, and other investment products
Equity 418.9 277.5 405.5 397.2
Fixed income, including money market 80.2 81.3 90.2 89.3
Multi-asset 195.2 149.6 205.9 189.4
694.3 508.4 701.6 675.9
Total $ 1,508.8 $ 1,162.7 $ 1,518.0 $ 1,470.5
Investors that we serve are primarily domiciled in the U.S.; investment advisory clients outside the U.S. account for 8.8 % and 9.3 % of our assets under management at March 31, 2021, and December 31, 2020, respectively.
Page 8
NOTE 3 – INVESTMENTS.
The carrying values of our investments that are not part of the consolidated T. Rowe Price investment products are as follows:
(in millions) 3/31/2021 12/31/2020
Investments held at fair value
T. Rowe Price investment products
Discretionary investments $ 1,664.3 $ 1,647.7
Seed capital 269.5 169.5
Supplemental savings plan liability economic hedges 766.9 768.1
Investment partnerships and other investments 100.6 95.1
Equity method investments
T. Rowe Price investment products
Discretionary investments 245.8 242.9
Seed capital 203.7 178.6
23 % investment in UTI Asset Management Company Limited (India)
149.1 145.5
Investment partnerships and other investments 2.7 2.4
U.S. Treasury note 1.0 1.0
Total $ 3,403.6 $ 3,250.8
The investment partnerships are carried at fair value using net asset value (“NAV”) per share as a practical expedient. Our interests in these partnerships are generally not redeemable and are subject to significant transferability restrictions. The underlying investments of these partnerships have contractual terms through 2029, though we may receive distributions of liquidating assets over a longer term. The investment strategies of these partnerships include growth equity, buyout, venture capital, and real estate.
During the three months ended March 31, 2021, net gains on investments included $ 38.8 million of net unrealized gains related to investments held at fair value that were still held at March 31, 2021. For the same period of 2020, net losses on investments included $ 103.6 million of net unrealized losses related to investments held at fair value that were still held at March 31, 2020.
During the three months ended March 31, 2021 and 2020, certain T. Rowe Price investment products in which we provided initial seed capital at the time of formation were deconsolidated, as we no longer had a controlling interest. Depending on our ownership interest, we are now reporting our residual interests in these T. Rowe Price investment products as either an equity method investment or an investment held at fair value. Additionally, during the three months ended March 31, 2020, certain T. Rowe Price investment products that were being accounted for as equity method investments were consolidated, as we regained a controlling interest. The net impact of these changes on our unaudited condensed consolidated balance sheets and statements of income as of the dates the portfolios were deconsolidated or reconsolidated is detailed below.
Three months ended
(in millions) 3/31/2021 3/31/2020
Net decrease in assets of consolidated T. Rowe Price investment products $ ( 928.1 ) $ ( 46.2 )
Net decrease in liabilities of consolidated T. Rowe Price investment products $ ( 15.3 ) $ ( 2.4 )
Net decrease in redeemable non-controlling interests $ ( 739.9 ) $ ( 20.1 )
Gains recognized upon deconsolidation $ 2.6 $ .1
The gains or losses recognized upon deconsolidation were the result of reclassifying currency translation adjustments accumulated on certain T. Rowe Price investment products with non-USD functional currencies from accumulated other comprehensive income to non-operating income.
Page 9
VARIABLE INTEREST ENTITIES.
Our investments at March 31, 2021 and December 31, 2020, include interests in variable interest entities that we do not consolidate as we are not deemed the primary beneficiary. Our maximum risk of loss related to our involvement with these entities is as follows:
(in millions) 3/31/2021 12/31/2020
Investment carrying values $ 289.6 $ 144.7
Unfunded capital commitments 11.3 12.3
Accounts receivable 60.7 13.8
$ 361.6 $ 170.8
The unfunded capital commitments totaling $ 11.3 million at March 31, 2021 and $ 12.3 million at December 31, 2020 relate primarily to the investment partnerships in which we have an existing investment. In addition to such amounts, a percentage of prior distributions may be called under certain circumstances.
NOTE 4 – FAIR VALUE MEASUREMENTS.
We determine the fair value of our cash equivalents and investments held at fair value using the following broad levels of inputs as defined by related accounting standards:
Level 1 – quoted prices in active markets for identical securities.
Level 2 – observable inputs other than Level 1 quoted prices including, but not limited to, quoted prices for similar
securities, interest rates, prepayment speeds, and credit risk. These inputs are based on market data
obtained from independent sources.
Level 3 – unobservable inputs reflecting our own assumptions based on the best information available. We do not
value any investments using Level 3 inputs.
These levels are not necessarily an indication of the risk or liquidity associated with our investments. The following table summarizes our investments that are recognized in our unaudited condensed consolidated balance sheets using fair value measurements determined based on the differing levels of inputs. This table excludes investments held by the consolidated T. Rowe Price investment products which are presented separately on our unaudited condensed consolidated balance sheets and are detailed in Note 5.
3/31/2021 12/31/2020
(in millions) Level 1
Level 2
Level 1
Level 2
T. Rowe Price investment products
Cash equivalents held in money market funds 2,487.5 $ — $ 1,931.1 $ —
Discretionary investments 1,664.3 — 1,647.7 —
Seed capital 254.6 14.9 156.6 12.9
Supplemental savings plan liability economic hedges 766.9 768.1 —
Other investments .2 .7 .5 .6
Total $ 5,173.5 $ 15.6 $ 4,504.0 $ 13.5
The fair value hierarchy level table above does not include the investment partnerships and other investments for which fair value is estimated using their NAV per share as a practical expedient. The carrying value of these investments as disclosed in Note 3 were $ 99.7 million at March 31, 2021, and $ 94.0 million at December 31, 2020.
NOTE 5 – CONSOLIDATED T. ROWE PRICE INVESTMENT PRODUCTS.
The T. Rowe Price investment products that we consolidate in our unaudited condensed consolidated financial statements are generally those products we provided initial seed capital at the time of their formation and have a controlling interest. Our U.S. mutual funds are considered voting interest entities, while those regulated outside the U.S. are considered variable interest entities.
Page 10
The following table details the net assets of the consolidated T. Rowe Price investment products:
3/31/2021 12/31/2020
(in millions)
Voting
interest entities
Variable interest entities
Total
Voting
interest entities
Variable interest entities
Total
Cash and cash equivalents (1)
$ 3.0 $ 80.7 $ 83.7 $ 7.1 $ 97.7 $ 104.8
Investments (2)
157.5 1,664.5 1,822.0 188.2 2,372.7 2,560.9
Other assets 3.4 37.7 41.1 2.8 27.0 29.8
Total assets 163.9 1,782.9 1,946.8 198.1 2,497.4 2,695.5
Liabilities 4.7 49.0 53.7 10.0 47.7 57.7
Net assets $ 159.2 $ 1,733.9 $ 1,893.1 $ 188.1 $ 2,449.7 $ 2,637.8
Attributable to T. Rowe Price Group $ 96.4 $ 783.8 $ 880.2 $ 130.7 $ 945.4 $ 1,076.1
Attributable to redeemable non-controlling interests 62.8 950.1 1,012.9 57.4 1,504.3 1,561.7
$ 159.2 $ 1,733.9 $ 1,893.1 $ 188.1 $ 2,449.7 $ 2,637.8
(1) Cash and cash equivalents includes $ 2.8 million at March 31, 2021, and $ 7.0 million at December 31, 2020, of T. Rowe Price money market mutual funds.
(2) Investments include $ 24.4 million at March 31, 2021, and $ 26.9 million at December 31, 2020 of other T. Rowe Price investment products.
Although we can redeem our net interest in these consolidated T. Rowe Price investment products at any time, we cannot directly access or sell the assets held by these products to obtain cash for general operations. Additionally, the assets of these investment products are not available to our general creditors.
Since third party investors in these investment products have no recourse to our credit, our overall risk related to the net assets of consolidated T. Rowe Price investment products is limited to valuation changes associated with our net interest. We, however, are required to recognize the valuation changes associated with all underlying investments held by these products in our unaudited condensed consolidated statements of income and disclose the portion attributable to third party investors as net income attributable to redeemable non-controlling interests.
The operating results of the consolidated T. Rowe Price investment products for the three months ended March 31, 2021 and 2020, are reflected in our unaudited condensed consolidated statements of income as follows:
Three months ended
3/31/2021 3/31/2020
(in millions)
Voting interest entities Variable interest entities Total Voting interest entities Variable interest entities Total
Operating expenses reflected in net operating income $ ( .2 ) $ ( 3.3 ) $ ( 3.5 ) $ ( .2 ) $ ( 3.5 ) $ ( 3.7 )
Net investment income (loss) reflected in non-operating income (loss) 6.1 31.1 37.2 ( 35.2 ) ( 295.1 ) ( 330.3 )
Impact on income before taxes $ 5.9 $ 27.8 $ 33.7 $ ( 35.4 ) $ ( 298.6 ) $ ( 334.0 )
Net income (loss) attributable to T. Rowe Price Group $ 4.0 $ 14.3 $ 18.3 $ ( 22.6 ) $ ( 134.9 ) $ ( 157.5 )
Net income (loss) attributable to redeemable non-controlling interests 1.9 13.5 15.4 ( 12.8 ) ( 163.7 ) ( 176.5 )
$ 5.9 $ 27.8 $ 33.7 $ ( 35.4 ) $ ( 298.6 ) $ ( 334.0 )
The operating expenses of the consolidated investment products are reflected in other operating expenses. In preparing our unaudited condensed consolidated financial statements, we eliminated operating expenses of $ 1.3 million and $ 2.5 million for the three months ended March 31, 2021 and 2020, respectively, against the investment advisory and administrative fees earned from these products. The net investment income (loss) reflected in non-
Page 11
operating income (loss) includes dividend and interest income and realized and unrealized gains and losses on the underlying securities held by the consolidated T. Rowe Price investment products.
The table below details the impact of these consolidated investment products on the individual lines of our unaudited condensed consolidated statements of cash flows for the three months ended March 31, 2021 and 2020.
Three months ended
3/31/2021 3/31/2020
(in millions)
Voting
interest entities
Variable interest entities
Total
Voting
interest entities
Variable interest entities
Total
Net cash provided by (used in) operating activities $ ( 31.7 ) $ ( 112.0 ) $ ( 143.7 ) $ 11.3 $ ( 87.0 ) $ ( 75.7 )
Net cash used in investing activities ( 9.1 ) ( 18.2 ) ( 27.3 ) ( .8 ) — ( .8 )
Net cash provided by financing activities 36.7 112.3 149.0 2.7 116.2 118.9
Effect of exchange rate changes on cash and cash equivalents of consolidated
T. Rowe Price investment products
— .9 .9 — ( 1.2 ) ( 1.2 )
Net change in cash and cash equivalents during period
( 4.1 ) ( 17.0 ) ( 21.1 ) 13.2 28.0 41.2
Cash and cash equivalents at beginning of year
7.1 97.7 104.8 9.9 66.6 76.5
Cash and cash equivalents at end of period
$ 3.0 $ 80.7 $ 83.7 $ 23.1 $ 94.6 $ 117.7
The net cash provided by financing activities during the three months ended March 31, 2021 and 2020 includes $ 34.1 million and $ 42.8 million, respectively, of net subscriptions we made into the consolidated T. Rowe Price investment products, net of dividends received. These cash flows were eliminated in consolidation.
FAIR VALUE MEASUREMENTS.
We determine the fair value of investments held by consolidated T. Rowe Price investment products using the following broad levels of inputs as defined by related accounting standards:
Level 1 – quoted prices in active markets for identical securities.
Level 2 – observable inputs other than Level 1 quoted prices including, but not limited to, quoted prices for similar securities, interest rates, prepayment speeds, and credit risk. These inputs are based on market data obtained from independent sources.
Level 3 – unobservable inputs reflecting our own assumptions based on the best information available. The value of investments using Level 3 inputs is insignificant.
These levels are not necessarily an indication of the risk or liquidity associated with these investment holdings. The following table summarizes the investment holdings held by our consolidated T. Rowe Price investment products using fair value measurements determined based on the differing levels of inputs.
3/31/2021 12/31/2020
(in millions)
Level 1
Level 2
Level 1
Level 2
Assets
Cash equivalents $ 2.8 $ — $ 7.0 $ —
Equity securities 225.7 449.9 308.0 708.0
Fixed income securities — 1,107.2 — 1,411.3
Other investments 4.0 35.2 2.6 131.0
$ 232.5 $ 1,592.3 $ 317.6 $ 2,250.3
Liabilities $ ( .4 ) $ ( 9.9 ) $ ( .4 ) $ ( 18.8 )
Page 12
NOTE 6 – STOCKHOLDERS’ EQUITY.
Accounts payable and accrued expenses includes liabilities of $ 10.9 million at March 31, 2021, and $ 2.5 million at December 31, 2020, for common stock repurchases that settled during the first week of April 2021 and January 2021, respectively.
NOTE 7 – STOCK-BASED COMPENSATION.
STOCK OPTIONS.
The following table summarizes the status of, and changes in, our stock options during the three months ended March 31, 2021.
Options Weighted-
average
exercise
price
Outstanding at December 31, 2020 4,329,056 $ 72.52
Exercised ( 748,203 ) $ 72.28
Outstanding at March 31, 2021 3,580,853 $ 72.57
Exercisable at March 31, 2021 3,580,853 $ 72.57
RESTRICTED SHARES AND STOCK UNITS.
The following table summarizes the status of, and changes in, our nonvested restricted shares and restricted stock units during the three months ended March 31, 2021.
Restricted
shares
Restricted
stock
units
Weighted-average
fair value
Nonvested at December 31, 2020 7,412 6,367,059 $ 116.51
Time-based grants — 3,397 $ 154.03
Dividend equivalents granted to non-employee directors — 550 $ 172.22
Vested — ( 64,942 ) $ 97.37
Forfeited — ( 19,489 ) $ 114.66
Nonvested at March 31, 2021 7,412 6,286,575 $ 116.73
Nonvested at March 31, 2021, includes performance-based restricted stock units of 361,609 . These nonvested performance-based restricted stock units include 198,205 units for which the performance period has lapsed, and the performance threshold has been met.
FUTURE STOCK-BASED COMPENSATION EXPENSE.
The following table presents the compensation expense to be recognized over the remaining vesting periods of the stock-based awards outstanding at March 31, 2021. Estimated future compensation expense will change to reflect future grants of restricted stock awards and units, future option grants, changes in the probability of performance thresholds being met, and adjustments for actual forfeitures.
(in millions)
Second quarter 2021 $ 56.9
Third quarter 2021 56.7
Fourth quarter 2021 50.2
2022 117.4
2023 through 2026 97.2
Total $ 378.4
Page 13
NOTE 8 – EARNINGS PER SHARE CALCULATIONS.
The following table presents the reconciliation of net income attributable to T. Rowe Price Group to net income allocated to our common stockholders and the weighted-average shares that are used in calculating the basic and diluted earnings per share on our common stock. Weighted-average common shares outstanding assuming dilution reflects the potential dilution, determined using the treasury stock method, that could occur if outstanding stock options were exercised and non-participating stock awards vested. No outstanding stock options had an anti-dilutive impact on the diluted earnings per common share calculation in the periods presented.
Three months ended
(in millions) 3/31/2021 3/31/2020
Net income attributable to T. Rowe Price Group 749.4 $ 343.1
Less: net income allocated to outstanding restricted stock and stock unit holders 19.9 9.4
Net income allocated to common stockholders $ 729.5 $ 333.7
Weighted-average common shares
Outstanding 227.7 234.1
Outstanding assuming dilution 230.0 236.8
NOTE 9 – OTHER COMPREHENSIVE INCOME AND ACCUMULATED OTHER COMPREHENSIVE LOSS.
The changes in each component of accumulated other comprehensive loss, including reclassification adjustments for the three months ended March 31, 2021 and 2020 are presented in the table below.
Three months ended 3/31/2021 Three months ended 3/31/2020
(in millions) Equity method investments Consolidated T. Rowe Price investment products - variable interest entities Total currency translation adjustments
Equity method investments Consolidated T. Rowe Price investment products - variable interest entities Total currency translation adjustments
Balances at beginning of period $ ( 43.6 ) $ 20.6 $ ( 23.0 ) $ ( 46.9 ) $ 3.9 $ ( 43.0 )
Other comprehensive income (loss) before reclassifications and income taxes
( .8 ) ( 7.1 ) ( 7.9 ) ( .1 ) ( 7.9 ) ( 8.0 )
Reclassification adjustments recognized in non-operating income
— ( 2.6 ) ( 2.6 ) — ( .1 ) ( .1 )
( .8 ) ( 9.7 ) ( 10.5 ) ( .1 ) ( 8.0 ) ( 8.1 )
Net deferred tax benefits (income taxes)
.5 2.5 3.0 — 2.0 2.0
Other comprehensive income (loss)
( .3 ) ( 7.2 ) ( 7.5 ) ( .1 ) ( 6.0 ) ( 6.1 )
Balances at end of period $ ( 43.9 ) $ 13.4 $ ( 30.5 ) $ ( 47.0 ) $ ( 2.1 ) $ ( 49.1 )
The other comprehensive income (loss) in the table above excludes $ 11.8 million and $ 17.2 million of other comprehensive loss related to redeemable non-controlling interests held in our consolidated products for the three months ended March 31, 2021 and 2020, respectively.
Page 14
NOTE 10 – COMMITMENTS AND CONTINGENCIES.
On February 14, 2017, T. Rowe Price Group, Inc., T. Rowe Price Associates, Inc., T. Rowe Price Trust Company, current and former members of the management committee, and trustees of the T. Rowe Price U.S. Retirement Program were named as defendants in a lawsuit filed in the United States District Court for the District of Maryland. The lawsuit alleges breaches of ERISA’s fiduciary duty and prohibited transaction provisions on behalf of a class of all participants and beneficiaries of the T. Rowe Price 401(k) Plan from February 14, 2011, to the time of judgment. The matter has been certified as a class action. T. Rowe Price believes the claims are without merit and is vigorously defending the action. The parties each filed motions for summary judgment and, with the exception of one claim, the court has denied the parties’ cross motions for summary judgment. A trial has been scheduled to begin in September 2021. We cannot predict the eventual outcome, or whether it will have a material negative impact on our financial results, or estimate the possible loss or range of loss that may arise from any negative outcome.
In addition to the matter discussed above, various claims against us arise in the ordinary course of business, including employment-related claims. In the opinion of management, after consultation with counsel, the likelihood of an adverse determination in one or more of these pending ordinary course of business claims that would have a material adverse effect on our financial position or results of operations is remote.
Page 15
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Stockholders and Board of Directors
T. Rowe Price Group, Inc.:
Results of Review of Interim Financial Information
We have reviewed the condensed consolidated balance sheet of T. Rowe Price Group, Inc. and subsidiaries (the “Company") as of March 31, 2021, the related condensed consolidated statements of income and comprehensive income, stockholders’ equity, and cash flows for the three-month periods ended March 31, 2021 and 2020, and the related notes (collectively, the consolidated interim financial information). Based on our reviews, we are not aware of any material modifications that should be made to the consolidated interim financial information for it to be in conformity with U.S. generally accepted accounting principles.
We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheet of the Company as of December 31, 2020, and the related consolidated statements of income, comprehensive income, stockholders’ equity, and cash flows for the year then ended (not presented herein); and in our report dated February 11, 2021, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2020, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.
Basis for Review Results
This consolidated interim financial information is the responsibility of the Company’s management. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our reviews in accordance with the standards of the PCAOB. A review of consolidated interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.
/s/ KPMG LLP
Baltimore, Maryland
April 29, 2021
Page 16
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.